n--nitrosoanatabine and Lung-Neoplasms

n--nitrosoanatabine has been researched along with Lung-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for n--nitrosoanatabine and Lung-Neoplasms

ArticleYear
Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats.
    Journal of cancer research and clinical oncology, 1984, Volume: 108, Issue:1

    Tobacco and tobacco smoke contain relatively high amounts of four tobacco-specific N-nitrosamines. Of these, N-nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and N'-nitrosoanatabine (NAT) were bioassayed at three dose levels by subcutaneous injections into male and female F344 rats in 60 subdoses amounting in total to 9,3, and 1 mmol/kg. Compared with the solvent control group (trioctanoin), both NNN and NNK induced significant numbers of tumors of the nasal cavity (P less than 0.01) at all three dose levels in both male and female rats. Significant numbers of tumors were also induced by NNK in the lung at all three dose levels and in the liver at the highest dose level (P less than 0.05). In addition to nasal tumors NNN also induced esophageal tumors at a significant rate in male rats at the high and medium dose levels and in female rats at the high level (P less than 0.05); NAT was inactive at the three doses tested. Bioassays at lower dose levels as well as biochemical studies are strongly indicated for NNN and NNK since these nitrosamines occur in relatively high amounts in both chewing tobacco and tobacco smoke.

    Topics: Animals; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Male; Neoplasms, Experimental; Nicotiana; Nitrosamines; Nose Neoplasms; Plants, Toxic; Rats; Rats, Inbred F344

1984